Working… Menu

An Efficacy and Safety Study of Ezetimibe (MK-0653, SCH 58235) in Addition to Atorvastatin Compared to Placebo in Participants With Primary Hypercholesterolemia (MK-0653-013)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03867110
Recruitment Status : Completed
First Posted : March 7, 2019
Last Update Posted : June 13, 2019
Information provided by (Responsible Party):
Merck Sharp & Dohme Corp.